Clinical trials, a therapeutic opportunity for the cancer patient Published on 20/05/2024 Since its launch, MD Anderson Madrid – Hospiten's Phase I Clinical Trials Unit has recruited 1,064 patients for participation in 373 clinical trials.
A third of registered and authorised clinical trials in Spain are focused on medications for the treatment of cancer Published on 19/05/2023 The lines of research of the Phase I Clinical Trials Unit are principally focused on lung cancer, melanoma and head and neck cancer. Since opening in 2021, the Unit has recruited 375 patients and is currently working on 199 active trials in all phases, 54 of which are Phase I
MD Anderson Madrid – Hospiten inaugurates their Phase I Clinical Trials Unit, one of the largest in Spain and Europe dedicated to the first phase of research Published on 03/11/2021 Advised directly from Houston, the unit will focus on research into the most promising cancer drugs in clinical development worldwide. It is estimated that more than 40 clinical studies in phase I will be investigated simultaneously